Schizophrenia

Recent Articles

RELATED ARTICLES

  1. Earnings blow for CSPC Pharma
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  2. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  3. Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  4. Cancer drug maker Genfleet joins Hong Kong IPO influx
  5. After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
    2696.HK
  6. Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
  7. Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva